<DOC>
	<DOCNO>NCT02839122</DOCNO>
	<brief_summary>This open-Label , A Randomized , Crossover study evaluate safety pharmacokinetic interaction oral concomitant administration Dutasteride Tadalafil healthy male volunteer .</brief_summary>
	<brief_title>A Study Investigate Pharmacokinetic Drug Interactions Between Dutasteride Tadalafil Healthy Male Subjects</brief_title>
	<detailed_description />
	<mesh_term>Hyperplasia</mesh_term>
	<mesh_term>Prostatic Hyperplasia</mesh_term>
	<mesh_term>Dutasteride</mesh_term>
	<mesh_term>Tadalafil</mesh_term>
	<criteria>Age 19 45 year BMI score 19 kg/m2 28 kg/m2 SBP &lt; 140 mmHg ≤ 90 mmHg DBP &lt; 90 mmHg ≥ 50 mmHg Eligible accord laboratory result hematology , blood chemistry urinalysis Voluntarily sign informed consent form Gastrointestinal diseases surgery may affect absorption investigational product within 6 month History hypersensitivity History Cardiovascular disease History degenerative Retina disease Lactose intolerance History vision loss Clinically significant disorder allergy , drug hypersensitivity reaction , hepatobiliary system , kidney , neurology , respiratory , hematooncology , endocrine , dermatology , urology , ophthalmology , psychiatry , musculoskeletal system , immunology , otorhinolaryngology , cardiovascular system Donated whole blood ( transfusion , apheresis etc.. ) within 60 day Participated administered investigational product clinical trial within 90 day Taking drug may affect Clinical trial within 30 day Excessive alcohol consumption ( &gt; 3 units/week , 1 unit ) Taking food may affect Clinical trial within 7 day Positive result Urinary test , Serum test Not eligible due reason include laboratory result Clinically significant disorder result Electrocardiography test Not eligible due investigator 's judgment</criteria>
	<gender>Male</gender>
	<minimum_age>19 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>April 2017</verification_date>
	<keyword>Dutasteride</keyword>
	<keyword>Tadalafil</keyword>
</DOC>